An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from the University of Toronto and Manchester University.
Their work, published today in the journal Medical Mycology, has also re-estimated the total number of asthmatics worldwide – to reveal a staggering 193 million sufferers. Twenty-four million asthma sufferers live in the United States, 20 million each in India and China, and seven million in the United Kingdom.
Clinical studies have shown that oral antifungal drugs significantly improve symptoms and asthma control in asthmatics with ABPA, treatment endorsed by the Cochrane Collaboration. This is the first time that a global estimate of ABPA numbers has been made.
In national league tables of asthma rates in adults, only Australia and Sweden have a higher prevalence than the UK. In global league tables of ABPA occurrence, New Zealand tops the list with a 3.5% rate in new patients attending chest clinics at hospitals. The rates were 2.6% in Cape Town, 2.3% in Saudi Arabia, 2.5% in China and 0.7% in an older study from Ireland. No population-based studies have been done.
In addition to standard asthma therapy, the antifungal therapy used is itraconazole – now a generic, inexpensive antifungal – with a response rate of 60%. The researchers also found that antifungal therapy also benefits patients with severe asthma sensitized to fungi, called SAFS.
Alternatives include voriconazole and posaconazole, which have 75-80% response rates. In a recent assessment of voriconazole and posaconazole for both ABPA and SAFS, 75% of patients were able to stop taking oral corticosteroids, a major benefit, and 38% of patients had their asthma severity downgraded on antifungal therapy.
Professor David Denning, professor of medicine and medical mycology at the University of Manchester and Director of the University Hospital of South Manchester’s National Aspergillosis Centre, led the study into the total number of asthmatics worldwide. He said the study results implied that asthma admissions and deaths could be avoided with more extensive use of antifungal therapy.
“We were surprised by the number of patients with ABPA, and by the lack of community based studies done,” he said. “Our National Aspergillosis Centre treats hundreds of these patients each year, generally with major improvement, and so a conscious program to seek out ABPA from all asthmatics is required.”
The Latest Bing News on:
Antifungal Therapy
- Top 6 Best Caprylic Acid Supplements in 2024on April 25, 2024 at 5:00 pm
Can caprylic acid be used as an antifungal treatment? Caprylic acid is believed to have antifungal properties and may be effective in treating Candida overgrowth. However, more research is needed ...
- Mundipharma to acquire rezafungin assets from Cidara Therapeuticson April 25, 2024 at 6:39 am
Mundipharma has signed an agreement to acquire all assets and rights related to antifungal candidate REZZAYO (rezafungin) from Cidara Therapeutics, including ongoing development and distribution.
- Systemic Antifungal Therapy for Cutaneous Infections in Childrenon April 24, 2024 at 5:00 pm
Cutaneous fungal infections that generally require systemic antifungal therapy include tinea capitis and onychomycosis. Tinea capitis, which is most often caused by Trichophyton tonsurans ...
- Global Tinea Pedis Treatment Market Set to Skyrocket, Reaching US$ 2.24 Billion by 2032on April 22, 2024 at 8:01 pm
Tinea Pedis Treatment Market is projected to an impressive US$ 2.24 billion by the end of 2032, reflecting a remarkable CAGR of 5.2%.
- Combination Antifungal Therapy for Invasive Fungal Infections in Children and Adultson April 20, 2024 at 5:00 pm
Data must be supported by adverse event profile and pharmacoeconomic impact of dual- or even triple-antifungal therapy. A prospective, multicenter study in solid-organ transplant recipients was ...
- Pulmocide’s inhaled antifungal shows promise in lung transplant patientson April 16, 2024 at 6:09 am
Pulmocide has said that opelconazole was also well tolerated with just two discontinuations in the Phase II trial.
- Pulmocide exits OPERA with phase 2 evidence of antifungal safety and efficacyon April 15, 2024 at 6:41 am
Pulmocide saw a lower rate of drug-drug interactions that lead to discontinuation of the antifungal or an immunosuppressant in the opelconazole arm than the control group. Opelconazole won that battle ...
- Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazoleon April 15, 2024 at 5:33 am
Inhaled opelconazole observed to be generally well tolerated in this study as prophylaxis against pulmonary aspergillosis in lung transplant ...
- How grinding teeth impacts oral healthon April 2, 2024 at 5:30 am
Oral candidiasis with white or erythematous lesions may occur. Treatment options include antifungal therapy for uncomplicated cases. Bruxism is a repetitive muscular activity of the jaw that is ...
- Top 8 Best Antifungal Supplements in 2024on March 30, 2024 at 5:01 pm
Antifungal dietary supplements can aid in ... and functions. The Clear Nails treatment helps restore healthy nails, appearance, and color, and targets yellow brittle toenails at the source.
The Latest Google Headlines on:
Antifungal Therapy
[google_news title=”” keyword=”Antifungal Therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Asthma
- How to help your cat breathe easy with feline asthmaon April 27, 2024 at 1:00 am
Spring is often described as a time of renewal and beauty, with flowers blooming and trees budding. However, spring flowers and budding trees also cause higher pollen counts, and for those with asthma ...
- FDA approves asthma drug for treating food allergieson April 25, 2024 at 1:03 pm
A drug newly approved by the Food and Drug Administration to reduce the risk of allergic reactions from food could bring relief to millions across the nation.
- More Cases of Asthma, COPD, Hypertension After Military Burn Pit Exposureon April 25, 2024 at 12:51 pm
Veterans in the highest tertile of burn pit exposure (340 days or more) had a 10% higher odds of asthma, a 22% higher odds of COPD, and a 10% higher odds of hypertension when compared with those with ...
- Signs and Symptoms of an Asthma Attackon April 25, 2024 at 12:00 pm
An asthma attack can cause mild to severe symptoms. Coughing, wheezing, change in breathing patterns, and difficulty breathing are some common symptoms.
- Complacency Leading To Thousands Of U.K. Asthma Deaths, Charity Sayson April 24, 2024 at 9:01 pm
The number of people dying from asthma in the U.K. is rising, with hundreds “needlessly” passing from the disease every year, a charity has warned. Around 12,000 people died of asthma in the country ...
- Mother's asthma plea after daughter's sudden deathon April 24, 2024 at 2:55 pm
The mother of a schoolgirl who died after an asthma attack has said sufferers should have regular checks to avoid "preventable" deaths like her daughter. Tracy Bulpitt's daughter Katy was 12-years-old ...
- New algorithm could provide early warning for asthma attackson April 24, 2024 at 11:45 am
A University of Texas at Dallas researcher and his international colleagues have developed an algorithm that might one day provide early medical alerts about the onset of asthma attacks or other ...
- Novartis accused of promoting asthma drug for preterm labor despite brain riskon April 23, 2024 at 10:24 am
Novartis has been hit with a lawsuit by people with autism and their mothers alleging the drugmaker illegally promoted an asthma drug for treatment of preterm labor despite knowing it was ineffective ...
- Local Doctor Explains How To Best Treat Asthmaon April 23, 2024 at 7:31 am
One in 13 people in the US have asthma, and one in 10 school-aged children have asthma. Dr. Stacy Chronister is an internal medicine specialist with OSU Medicine and joins us with some helpful ...
- ‘Kids need to breathe just like adults do’: $35 price caps don’t apply to asthma meds young children need, doctors sayon April 17, 2024 at 1:21 pm
Some makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35. But those pledges don’t apply to daily inhalers used by the youngest kids, ...
The Latest Google Headlines on:
Asthma
[google_news title=”” keyword=”asthma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]